Asthma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who have been diagnosed with bronchial asthma in the past, are able to visit Keio University Hospital, and meet at least one of the following criteria - Obesity with a BMI of 25 or higher - Type 2 diabetes with HbA1c less than 8%. - Dyslipidemia - Hyperuricemia
Exclusion criteria
Exclusion criteria: - Pregnant or lactating mothers - Chronic kidney disease Grade 3a or higher or renal failure with eGFR less than 59 ml/min/1.73m2 - Type 1 diabetes or diabetes on insulin or type 2 diabetes with HbA1c more than or equal to 8%. - Patients with hypertension deemed poorly controlled by the clinician - Other conditions for which the clinician determines that the diet recommended in this study may be associated with an exacerbation of the underlying disease. - Those who cannot give consent to participate in the study. - Those who have difficulty using the contents of Oishi Kenko app.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in AQLQ (asthma-related quality of life) from baseline after 4 weeks of dietary intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in weight and body composition assessment from the baseline to 4 weeks and 8 weeks, and the following questionnaire. - Self-assessment of compliance with dietary intervention - Dietary survey including frequency of consumption of fermented foods, etc. - Symptom of asthma (ACQ-5) - Symptom of gastroesophageal reflux symptoms (FSSG) - Symptom of depression and anxiety (HADS) Questionnaire of the following items from the baseline to 4 weeks and 8 weeks. - Nutritional Questionnaire prepared by the National Institute of Biomedical Innovation, National Institute of Health and Nutrition (questionnaire used for analysis of intestinal bacteria) - Questionnaire prepared by the National Institute of Biomedical Innovation and Nutrition (questionnaire used for analysis of intestinal flora) The following laboratory data at the baseline, 4 weeks, and 8 weeks. - Blood samples: counting the number of white and red blood cells, TARC, airbone antigen-specific IgE, total IgE - LDL-C, HDL-C, lipoprotein, triglycerides, HbA1c, insulin, C-peptide, uric acid, zinc - Pulmonary function tests: spirometry, mostograph - Exhaled nitric oxide concentration (FeNO) | — |
Countries
Japan
Contacts
Keio University School of Medicine Division of Pulmonary Medicine, Department of Medicine